Aflac (NYSE:AFL) Announces Earnings Results

Aflac (NYSE:AFL) issued its quarterly earnings results on Thursday. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.76 by ($0.01), FiscalAI reports. Aflac had a return on equity of 13.37% and a net margin of 26.91%.The business had revenue of $4.22 billion during the quarter, compared to analysts’ expectations of $4.11 billion. During the same quarter in the previous year, the company posted $1.78 EPS. The company’s quarterly revenue was down 1.0% on a year-over-year basis.

Aflac Trading Down 1.6%

Shares of NYSE:AFL traded down $2.02 on Friday, hitting $124.64. 2,452,894 shares of the company’s stock were exchanged, compared to its average volume of 1,990,528. The stock has a market capitalization of $63.44 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 1.95 and a beta of 0.60. Aflac has a 12 month low of $101.49 and a 12 month high of $130.22. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.11 and a quick ratio of 0.11. The business’s 50 day simple moving average is $120.72 and its two-hundred day simple moving average is $115.37.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Stockholders of record on Wednesday, August 19th will be given a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Wednesday, August 19th. Aflac’s dividend payout ratio (DPR) is 27.70%.

Insider Activity at Aflac

In related news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.12, for a total value of $7,441,560.00. Following the transaction, the insider owned 51,169,435 shares of the company’s stock, valued at $6,044,133,662.20. This trade represents a 0.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 744,073 shares of company stock valued at $87,022,570 in the last quarter. Corporate insiders own 0.80% of the company’s stock.

Hedge Funds Weigh In On Aflac

A number of institutional investors have recently modified their holdings of AFL. Quarry LP purchased a new position in Aflac during the 4th quarter worth $25,000. Darwin Wealth Management LLC bought a new position in shares of Aflac during the 2nd quarter worth $33,000. Birchwood Financial Partners Inc. purchased a new position in shares of Aflac during the fourth quarter valued at $36,000. Ankerstar Wealth LLC purchased a new position in shares of Aflac during the fourth quarter valued at $48,000. Finally, Headlands Technologies LLC bought a new stake in shares of Aflac in the second quarter valued at about $67,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. TD Cowen reissued a “hold” rating and issued a $110.00 price objective (up from $101.00) on shares of Aflac in a research note on Wednesday, July 22nd. Wall Street Zen raised shares of Aflac from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Keefe, Bruyette & Woods lifted their price target on Aflac from $115.00 to $120.00 and gave the stock a “market perform” rating in a research report on Monday, July 13th. Morgan Stanley boosted their price objective on Aflac from $120.00 to $125.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 21st. Finally, Barclays restated an “underweight” rating and set a $99.00 price objective (up from $98.00) on shares of Aflac in a research report on Friday. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $116.25.

Trending Headlines about Aflac

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Aflac declared a quarterly dividend of $0.61 per share, payable September 1 to shareholders of record on August 19. The dividend represents an annualized payout of approximately $2.44 per share and a yield near 2.0%, supporting the stock’s income appeal. Aflac Announces Second Quarter 2026 Results and Dividend
• Positive Sentiment: Second-quarter revenue reached $4.22 billion, exceeding the roughly $4.11 billion consensus estimate. Management also highlighted solid U.S. sales, strong policy persistency and ongoing capital returns as signs of underlying business stability. Aflac Misses Q2 EPS Estimates Despite Solid US Sales Growth
• Neutral Sentiment: Aflac’s quarterly earnings call and presentation provided additional details on operating trends, sales momentum and financial performance for investors assessing the company’s outlook. Aflac Q2 2026 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were $1.75 per share, below analyst estimates ranging from $1.76 to $1.79 and down from $1.78 a year earlier. Lower investment income and unfavorable foreign-exchange effects, including a stronger dollar, weighed on profitability. Aflac Q2 Earnings Lag Estimates
• Negative Sentiment: Revenue declined approximately 1.0% year over year, while the earnings shortfall reinforces concerns about near-term investment income and currency headwinds. These factors likely explain the negative investor reaction despite the revenue beat. Aflac Q2 Earnings Snapshot

About Aflac

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.